Araldi G L, Donati D, Tranquillini M E, Ursini A
Glaxo Wellcome S.p.A., Medicines Research Centre, Verona, Italy.
Farmaco. 1998 Jan;53(1):49-54. doi: 10.1016/s0014-827x(97)00004-9.
The presence of a chain bearing a stereogenic centre at the N-5 position of 1-(1-adamantylmethyl)-3-arylureido-2,4-dioxo-1,5-benzodiazep ines induces optical resolution. The synthesis of these compounds and their potency as potential CCK-B receptor antagonists is discussed briefly here.